MSD has agreed to pay up to $610 million to acquire Caraway Therapeutics, a Cambridge, Massachusetts biotech focusing on neurodegenerative disorders and rare diseases. The big pharma, known as ...

Kelun-Biotech has become the second drugmaker to ... Daiichi's was re-filed for EGFR-positive NSCLC only. Outside China, MSD has rights to sac-TMT under the terms of a partnership signed in ...

Danish biotechnology company IO Biotech has finished enrolling subjects in a Phase II trial of its lead therapeutic cancer vaccine candidate, IO102-IO103, in conjunction with MSD's KEYTRUDA ...

Life science company Epitopea, rooted in Cambridge UK and both Montreal and Quebec in Canada, has clinched a licensing deal ...

MSD Pharma and Delhi Capitals join forces to raise awareness about cervical cancer prevention in India, aiming to educate ...

MSD Pharmaceuticals and Delhi Capitals have partnered to raise cervical cancer prevention awareness in India. The women's T20 team will display this message on their jerseys during matches. The ...